A real-world study of quality of life following treatment with xylometazoline hydrochloride in individuals with common cold
Background: The common cold is a frequent, acute, and mild upper respiratory human disease. Nasal congestion has been considered the most bothersome symptom in the common cold, impacting quality of life (QoL). Topical decongestants containing steroids benefit QoL in allergic rhinitis, but no publish...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publishing
2024-02-01
|
| סדרה: | Therapeutic Advances in Respiratory Disease |
| גישה מקוונת: | https://doi.org/10.1177/17534666241228927 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|